Analysis
What Changed
Unitree Robotics' STAR Market subscription and payment window closed on August 12, according to Gasgoo and Odaily's timeline coverage. Pulse covered the subscription opening on August 10; what's new today is that the window is now shut, allocation results are due August 14, and the actual trading debut has narrowed to a window between August 17 and 21, pending final confirmation from the Shanghai Stock Exchange.
The Deal Terms
Unitree priced its offering at 150.80 yuan per share on August 6, issuing roughly 40.45 million shares -- about 10% of post-offering capital -- to raise approximately $900 million and value the company near $9 billion, making it the first humanoid and quadruped robotics maker to go public on a major exchange.
Company Background
Founded in 2016 by Wang Xingxing, Unitree builds quadruped and humanoid robots and has distinguished itself from most Western humanoid-robotics startups by actually shipping and selling hardware at scale -- its quadruped robots have been commercially available for years, and the company has reportedly been profitable, a rarity in a category where most competitors are still burning venture capital pre-revenue.
The Competitive Field
Unitree's public listing puts it in an unusual competitive position relative to Figure AI and 1X Technologies, both of which remain privately held and have raised large venture rounds without significant commercial shipments, and Tesla's Optimus program, which is internally funded rather than independently capitalized. Boston Dynamics, owned by Hyundai, is the other major established player but has not pursued a public listing. AgiBot, a Chinese rival, is separately pursuing a Hong Kong listing around the same window, setting up a direct comparison between two Chinese humanoid-robotics IPOs within weeks of each other.
Numbers in Context
A $9 billion valuation for a profitable, revenue-generating robotics manufacturer is a meaningfully different kind of mark than the multi-billion-dollar private valuations Figure AI and other humanoid startups have raised on projected future capability rather than current shipments and revenue -- public investors will get an actual look at Unitree's real unit economics in ways private-market valuations for its unlisted competitors don't require.
The Counterweight
A STAR Market listing subjects Unitree to Chinese capital markets rules, disclosure standards and potential state-influenced trading dynamics that differ substantially from a Nasdaq or NYSE listing -- STAR Market IPOs have also historically traded with high volatility and steep first-week price-earnings multiples that don't always hold. Existing US restrictions on Chinese humanoid robots in some contexts add a separate layer of market-access risk that a Shanghai listing alone doesn't resolve for a company with global ambitions.
What's Next
The August 17-21 trading debut window is the number to watch next -- how Unitree's stock trades in its first sessions will be read across the industry as an early signal of how public markets price commercial robotics companies relative to the private valuations still being set for Figure AI, 1X and the rest of the humanoid field.
